India Recombinant Proteins Market: Can "Biopharma SHAKTI" Transform the Nation into the World’s Biologic Pharmacy?
The India Recombinant Proteins Market in 2026 is experiencing a paradigm shift thanks to the "Biopharma SHAKTI" initiative, a $1.2 billion government program aimed at scaling biologic production. This year, the market is moving away from basic generics and toward "High-Value Biologics" and novel recombinant vaccines. This shift is critical for the global Recombinant Proteins Market, as India...
0 Commentarii 0 Distribuiri 38 Views 0 previzualizare
JogaJog https://jogajog.com.bd